01/13/2012 03:24 EST | Updated 03/14/2012 05:12 EDT

Recall of Excedrin caplets extends to Canada, drug regulator says

TORONTO - Health Canada says a recall of Excedrin products announced earlier this week in the United States now extends to Canada.

The recall covers all lots of Excedrin Extra Strength Caplets and Excedrin Tension Headache Caplets with expiration dates of Dec. 20, 2014 or earlier.

The recall was initiated after the U.S. Food and Drug Administration received reports of chipped and broken pills.

As well, it had reports of inconsistent bottle packaging clearance practices, which could result in the bottles containing foreign tablets, caplets, or capsules.

The FDA informed consumers that mixing of different products in the same bottle could result in consumers taking a higher or lower dose than intended or receiving an unintended ingredient.

The products are marketed by Novartis Consumer Health Canada Inc., which is voluntarily recalling the drugs.

For information concerning the recall or how to return the drugs, consumers should directly contact Novartis Consumer Health Canada Inc.’s consumer relationship centre at 1-888-788-8181.